Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Double-blind Placebo-controlled Three-arm Parallel-group Clinical Study to Evaluate the Efficacy and Safety of DMB-I in the Treatment of Dementia Associated With Alzheimer's Disease

NCT06292351 is registered in ClinicalTrials.gov with Bigespas LTD as lead sponsor.

NCT NCT06292351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Double-blind Placebo-controlled Three-arm Parallel-group Clinical Study to Evaluate the Efficacy and Safety of DMB-I in the Treatment of Dementia Associated With Alzheimer's Disease
Lead sponsor
Bigespas LTD
Phase
Phase 2
Overall status
Completed
Start date
December 27, 2023
Completion date
January 31, 2025
Enrollment
133 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia of alzheimer type